TNFRSF11B and neoplasm: Recent studies have highlighted the potential of various biomarkers, including circulating tumor cells (CTCs), micro-RNAs, and proteins such as osteoprotegerin (OPG) and insulin-like growth factors (IGFs), which are involved in the pathogenesis of bone metastases [191,206,207].